Evidence map›Paper›PMID 40649925›Full record

ArticleInternational journal of molecular sciences2025

Altered HDL Phospholipid and Fatty Acid Profile in MASLD: A Possible Explanation for the Increased CVD Risk.

Sofia Kartsoli, Christina E Kostara, Athanasios Papathanasiou, Vasilis Tsimihodimos, Eleni T Bairaktari, Dimitrios K Christodoulou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sofia KartsoliDepartment of Gastroenterology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Christina E KostaraLaboratory of Clinical Chemistry, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0001-7045-1323
Athanasios PapathanasiouDepartment of Internal Medicine, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Vasilis TsimihodimosDepartment of Internal Medicine, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0003-1708-3415
Eleni T BairaktariLaboratory of Clinical Chemistry, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Dimitrios K ChristodoulouDepartment of Gastroenterology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0001-9694-1160

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) has been consistently linked to increased risk of cardiovascular disease (CVD). HDL lipoproteins may serve as a possible link in this association through their hepatic synthesis and atheroprotective properties. Serum samples were collected from 51 MASLD patients (diagnosed by abdominal ultrasound), 40 with coronary artery disease, and 50 healthy controls. HDL lipid profiles were investigated by proton nuclear magnetic resonance (

Indexed as

Cardiovascular DiseasesFatty AcidsLipoproteins, HDLPhospholipidsAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedFatty AcidsLipoproteins, HDLPhospholipidscoronary artery diseaseCVD riskfatty acidsHDLlipidomicslipoproteinsmetabolic dysfunction-associated steatotic liver diseaseNMRphospholipidssphingolipids

Identifiers

PMID40649925
PMCPMC12250491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.